APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Hemostats

Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.

Selected research

Market Outlook & Growth Opportunities

Global Hemostats Market Outlook and Growth Opportunities 2026

Report ID 173908190423 December 2025209 pages

Choose your research edition.

Industry ResearchHemostats Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Hemostats Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Hemostats Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hemostats Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Hemostats Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.

Global Hemostats key players include Ethicon, Inc., Pfizer, Inc., Baxter International Inc., C. R. Bard, The Medicines Company, etc. Global top five manufacturers hold a share over 55%.

North America is the largest market, with a share about 35%, followed by China, and Europe, both have a share over 35 percent.

Read the full market overview

In terms of product, Thrombin-Based Hemostats is the largest segment, with a share over 40%. And in terms of application, the largest application is Hospital Treatment, followed by Prehospital Treatment, etc.

This report provides an overview of the global Hemostats market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hemostats and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hemostats sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hemostats market size, projected growth trends, production technologies, key applications, and end-use industries.

Hemostats Segment by Company

Ethicon

Pfizer

Baxter International Inc.

C. R. Bard

The Medicines Company

Anika Therapeutics

Advanced Medical Solutions

Integra LifeSciences Corporation

B Braun Melsungen AG

Gelita Medical GmbH

Equimedical

Vascular Solutions

Marine Polymer Technologies

Z-Medica, LLC

CryoLife

BioCer Entwicklungs-GmbH.

Biom'Up SAS

Hemostats Segment by Type

Thrombin-Based Hemostats

Oxidized Regenerated Cellulose Based Hemostats

Combination Hemostats

Gelatin Based Hemostats

Collagen Based Hemostats

Hemostats Segment by Application

Prehospital Treatment

Hospital Treatment

Hemostats Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Hemostats status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Hemostats market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Hemostats significant trends, drivers, influence factors in global and regions.

6. To analyze Hemostats competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemostats market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hemostats and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemostats.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hemostats market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hemostats industry.

Chapter 3: Detailed analysis of Hemostats manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Hemostats in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Hemostats in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Hemostats Industry Trends Table 2. Hemostats Industry Drivers Table 3. Hemostats Industry Opportunities and Challenges Table 4. Hemostats Industry Restraints Table 5. Global Hemostats Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Hemostats Revenue Share by Company (2021-2026) Table 7. Global Hemostats Sales Volume by Company (K Pcs) & (2021-2026) Table 8. Global Hemostats Sales Volume Share by Company (2021-2026) Table 9. Global Hemostats Average Price (USD/Pcs) of Company (2021-2026) Table 10. Global Hemostats Company Ranking, (2024-2026) & (USD Million) Table 11. Global Hemostats Key Company Manufacturing Base & Headquarters Table 12. Global Hemostats Company, Product Type & Application Table 13. Global Hemostats Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Hemostats by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Thrombin-Based Hemostats Table 18. Significant Companies of Oxidized Regenerated Cellulose Based Hemostats Table 19. Significant Companies of Combination Hemostats Table 20. Significant Companies of Gelatin Based Hemostats Table 21. Significant Companies of Collagen Based Hemostats Table 22. Global Hemostats Sales Volume by Type 2021 VS 2025 VS 2032 (K Pcs) Table 23. Global Hemostats Sales Volume by Type (2021-2026) & (K Pcs) Table 24. Global Hemostats Sales Volume by Type (2027-2032) & (K Pcs) Table 25. Global Hemostats Sales Volume Share by Type (2021-2026) Table 26. Global Hemostats Sales Volume Share by Type (2027-2032) Table 27. Global Hemostats Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Hemostats Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Hemostats Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Hemostats Sales Value Share by Type (2021-2026) Table 31. Global Hemostats Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Prehospital Treatment Table 33. Significant Companies of Hospital Treatment Table 34. Global Hemostats Sales Volume by Application 2021 VS 2025 VS 2032 (K Pcs) Table 35. Global Hemostats Sales Volume by Application (2021-2026) & (K Pcs) Table 36. Global Hemostats Sales Volume by Application (2027-2032) & (K Pcs) Table 37. Global Hemostats Sales Volume Share by Application (2021-2026) Table 38. Global Hemostats Sales Volume Share by Application (2027-2032) Table 39. Global Hemostats Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Hemostats Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Hemostats Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Hemostats Sales Value Share by Application (2021-2026) Table 43. Global Hemostats Sales Value Share by Application (2027-2032) Table 44. Global Hemostats Sales by Region: 2021 VS 2025 VS 2032 (K Pcs) Table 45. Global Hemostats Sales by Region (2021-2026) & (K Pcs) Table 46. Global Hemostats Sales Market Share by Region (2021-2026) Table 47. Global Hemostats Sales by Region (2027-2032) & (K Pcs) Table 48. Global Hemostats Sales Market Share by Region (2027-2032) Table 49. Global Hemostats Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Hemostats Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Hemostats Sales Value Share by Region (2021-2026) Table 52. Global Hemostats Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Hemostats Sales Value Share by Region (2027-2032) Table 54. Global Hemostats Market Average Price (USD/Pcs) by Region (2021-2026) Table 55. Global Hemostats Market Average Price (USD/Pcs) by Region (2027-2032) Table 56. Global Hemostats Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 57. Global Hemostats Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Hemostats Sales by Country (2021-2026) & (K Pcs) Table 59. Global Hemostats Sales Market Share by Country (2021-2026) Table 60. Global Hemostats Sales by Country (2027-2032) & (K Pcs) Table 61. Global Hemostats Sales Market Share by Country (2027-2032) Table 62. Global Hemostats Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Hemostats Sales Value Market Share by Country (2021-2026) Table 64. Global Hemostats Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Hemostats Sales Value Market Share by Country (2027-2032) Table 66. Ethicon Company Information Table 67. Ethicon Business Overview Table 68. Ethicon Hemostats Sales (K Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 69. Ethicon Hemostats Product Portfolio Table 70. Ethicon Recent Development Table 71. Pfizer Company Information Table 72. Pfizer Business Overview Table 73. Pfizer Hemostats Sales (K Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 74. Pfizer Hemostats Product Portfolio Table 75. Pfizer Recent Development Table 76. Baxter International Inc. Company Information Table 77. Baxter International Inc. Business Overview Table 78. Baxter International Inc. Hemostats Sales (K Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 79. Baxter International Inc. Hemostats Product Portfolio Table 80. Baxter International Inc. Recent Development Table 81. C. R. Bard Company Information Table 82. C. R. Bard Business Overview Table 83. C. R. Bard Hemostats Sales (K Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 84. C. R. Bard Hemostats Product Portfolio Table 85. C. R. Bard Recent Development Table 86. The Medicines Company Company Information Table 87. The Medicines Company Business Overview Table 88. The Medicines Company Hemostats Sales (K Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 89. The Medicines Company Hemostats Product Portfolio Table 90. The Medicines Company Recent Development Table 91. Anika Therapeutics Company Information Table 92. Anika Therapeutics Business Overview Table 93. Anika Therapeutics Hemostats Sales (K Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 94. Anika Therapeutics Hemostats Product Portfolio Table 95. Anika Therapeutics Recent Development Table 96. Advanced Medical Solutions Company Information Table 97. Advanced Medical Solutions Business Overview Table 98. Advanced Medical Solutions Hemostats Sales (K Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 99. Advanced Medical Solutions Hemostats Product Portfolio Table 100. Advanced Medical Solutions Recent Development Table 101. Integra LifeSciences Corporation Company Information Table 102. Integra LifeSciences Corporation Business Overview Table 103. Integra LifeSciences Corporation Hemostats Sales (K Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 104. Integra LifeSciences Corporation Hemostats Product Portfolio Table 105. Integra LifeSciences Corporation Recent Development Table 106. B Braun Melsungen AG Company Information Table 107. B Braun Melsungen AG Business Overview Table 108. B Braun Melsungen AG Hemostats Sales (K Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 109. B Braun Melsungen AG Hemostats Product Portfolio Table 110. B Braun Melsungen AG Recent Development Table 111. Gelita Medical GmbH Company Information Table 112. Gelita Medical GmbH Business Overview Table 113. Gelita Medical GmbH Hemostats Sales (K Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 114. Gelita Medical GmbH Hemostats Product Portfolio Table 115. Gelita Medical GmbH Recent Development Table 116. Equimedical Company Information Table 117. Equimedical Business Overview Table 118. Equimedical Hemostats Sales (K Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 119. Equimedical Hemostats Product Portfolio Table 120. Equimedical Recent Development Table 121. Vascular Solutions Company Information Table 122. Vascular Solutions Business Overview Table 123. Vascular Solutions Hemostats Sales (K Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 124. Vascular Solutions Hemostats Product Portfolio Table 125. Vascular Solutions Recent Development Table 126. Marine Polymer Technologies Company Information Table 127. Marine Polymer Technologies Business Overview Table 128. Marine Polymer Technologies Hemostats Sales (K Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 129. Marine Polymer Technologies Hemostats Product Portfolio Table 130. Marine Polymer Technologies Recent Development Table 131. Z-Medica, LLC Company Information Table 132. Z-Medica, LLC Business Overview Table 133. Z-Medica, LLC Hemostats Sales (K Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 134. Z-Medica, LLC Hemostats Product Portfolio Table 135. Z-Medica, LLC Recent Development Table 136. CryoLife Company Information Table 137. CryoLife Business Overview Table 138. CryoLife Hemostats Sales (K Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 139. CryoLife Hemostats Product Portfolio Table 140. CryoLife Recent Development Table 141. BioCer Entwicklungs-GmbH. Company Information Table 142. BioCer Entwicklungs-GmbH. Business Overview Table 143. BioCer Entwicklungs-GmbH. Hemostats Sales (K Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 144. BioCer Entwicklungs-GmbH. Hemostats Product Portfolio Table 145. BioCer Entwicklungs-GmbH. Recent Development Table 146. Biom'Up SAS Company Information Table 147. Biom'Up SAS Business Overview Table 148. Biom'Up SAS Hemostats Sales (K Pcs), Value (US$ Million), Price (USD/Pcs) and Gross Margin (2021-2026) Table 149. Biom'Up SAS Hemostats Product Portfolio Table 150. Biom'Up SAS Recent Development Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Hemostats Distributors List Table 154. Hemostats Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Hemostats Product Image Figure 2. Global Hemostats Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hemostats Sales Value (2021-2032) & (US$ Million) Figure 4. Global Hemostats Sales (2021-2032) & (K Pcs) Figure 5. Global Hemostats Sales Average Price (USD/Pcs) & (2021-2032) Figure 6. Global Hemostats Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Thrombin-Based Hemostats Image Figure 10. Oxidized Regenerated Cellulose Based Hemostats Image Figure 11. Combination Hemostats Image Figure 12. Gelatin Based Hemostats Image Figure 13. Collagen Based Hemostats Image Figure 14. Global Hemostats Sales Volume by Type (2021 VS 2025 VS 2032) & (K Pcs) Figure 15. Global Hemostats Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Hemostats Sales Volume Share by Type (2021-2032) Figure 17. Global Hemostats Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Hemostats Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Hemostats Sales Value Share by Type (2021-2032) Figure 20. Prehospital Treatment Image Figure 21. Hospital Treatment Image Figure 22. Global Hemostats Sales Volume by Application (2021 VS 2025 VS 2032) & (K Pcs) Figure 23. Global Hemostats Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Hemostats Sales Volume Share by Application (2021-2032) Figure 25. Global Hemostats Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Hemostats Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Hemostats Sales Value Share by Application (2021-2032) Figure 28. Global Hemostats Sales by Region: 2021 VS 2025 VS 2032 (K Pcs) Figure 29. Global Hemostats Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Hemostats Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Hemostats Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Hemostats Sales Value (2021-2032) & (US$ Million) Figure 33. North America Hemostats Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Hemostats Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Hemostats Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Hemostats Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Hemostats Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Hemostats Sales Value (2021-2032) & (US$ Million) Figure 39. South America Hemostats Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Hemostats Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Hemostats Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Hemostats Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Hemostats Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Hemostats Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Hemostats Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Hemostats Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Thrombin-Based Hemostats
  • Oxidized Regenerated Cellulose Based Hemostats
  • Combination Hemostats
  • Gelatin Based Hemostats
  • Collagen Based Hemostats
Applications
  • Prehospital Treatment
  • Hospital Treatment
Companies covered
  • Ethicon
  • Pfizer
  • Baxter International Inc.
  • C. R. Bard
  • The Medicines Company
  • Anika Therapeutics
  • Advanced Medical Solutions
  • Integra LifeSciences Corporation
  • B Braun Melsungen AG
  • Gelita Medical GmbH
  • Equimedical
  • Vascular Solutions
  • Marine Polymer Technologies
  • Z-Medica, LLC
  • CryoLife
  • BioCer Entwicklungs-GmbH.
  • Biom'Up SAS

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hemostats Sales Value (2021-2032)
  4. 1.2.2 Global Hemostats Sales Volume (2021-2032)
  5. 1.2.3 Global Hemostats Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Hemostats Market Dynamics
  1. 2.1 Hemostats Industry Trends
  2. 2.2 Hemostats Industry Drivers
  3. 2.3 Hemostats Industry Opportunities and Challenges
  4. 2.4 Hemostats Industry Restraints
3 Hemostats Market by Company
  1. 3.1 Global Hemostats Company Revenue Ranking in 2025
  2. 3.2 Global Hemostats Revenue by Company (2021-2026)
  3. 3.3 Global Hemostats Sales Volume by Company (2021-2026)
  4. 3.4 Global Hemostats Average Price by Company (2021-2026)
  5. 3.5 Global Hemostats Company Ranking (2024-2026)
  6. 3.6 Global Hemostats Company Manufacturing Base and Headquarters
  7. 3.7 Global Hemostats Company Product Type and Application
  8. 3.8 Global Hemostats Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Hemostats Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Hemostats Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Hemostats Market by Type
  1. 4.1 Hemostats Type Introduction
  2. 4.1.1 Thrombin-Based Hemostats
  3. 4.1.2 Oxidized Regenerated Cellulose Based Hemostats
  4. 4.1.3 Combination Hemostats
  5. 4.1.4 Gelatin Based Hemostats
  6. 4.1.5 Collagen Based Hemostats
  7. 4.2 Global Hemostats Sales Volume by Type
  8. 4.2.1 Global Hemostats Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Hemostats Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Hemostats Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Hemostats Sales Value by Type
  12. 4.3.1 Global Hemostats Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Hemostats Sales Value by Type (2021-2032)
  14. 4.3.3 Global Hemostats Sales Value Share by Type (2021-2032)
5 Hemostats Market by Application
  1. 5.1 Hemostats Application Introduction
  2. 5.1.1 Prehospital Treatment
  3. 5.1.2 Hospital Treatment
  4. 5.2 Global Hemostats Sales Volume by Application
  5. 5.2.1 Global Hemostats Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Hemostats Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Hemostats Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Hemostats Sales Value by Application
  9. 5.3.1 Global Hemostats Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Hemostats Sales Value by Application (2021-2032)
  11. 5.3.3 Global Hemostats Sales Value Share by Application (2021-2032)
6 Hemostats Regional Sales and Value Analysis
  1. 6.1 Global Hemostats Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hemostats Sales by Region (2021-2032)
  3. 6.2.1 Global Hemostats Sales by Region: 2021-2026
  4. 6.2.2 Global Hemostats Sales by Region (2027-2032)
  5. 6.3 Global Hemostats Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Hemostats Sales Value by Region (2021-2032)
  7. 6.4.1 Global Hemostats Sales Value by Region: 2021-2026
  8. 6.4.2 Global Hemostats Sales Value by Region (2027-2032)
  9. 6.5 Global Hemostats Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Hemostats Sales Value (2021-2032)
  12. 6.6.2 North America Hemostats Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Hemostats Sales Value (2021-2032)
  15. 6.7.2 Europe Hemostats Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Hemostats Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Hemostats Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Hemostats Sales Value (2021-2032)
  21. 6.9.2 South America Hemostats Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Hemostats Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Hemostats Sales Value Share by Country, 2025 VS 2032
7 Hemostats Country-level Sales and Value Analysis
  1. 7.1 Global Hemostats Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Hemostats Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Hemostats Sales by Country (2021-2032)
  4. 7.3.1 Global Hemostats Sales by Country (2021-2026)
  5. 7.3.2 Global Hemostats Sales by Country (2027-2032)
  6. 7.4 Global Hemostats Sales Value by Country (2021-2032)
  7. 7.4.1 Global Hemostats Sales Value by Country (2021-2026)
  8. 7.4.2 Global Hemostats Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Hemostats Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Hemostats Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Hemostats Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Hemostats Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Hemostats Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Hemostats Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Hemostats Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Hemostats Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Hemostats Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Hemostats Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Hemostats Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Hemostats Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Hemostats Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Hemostats Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Hemostats Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Hemostats Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Hemostats Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Hemostats Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Hemostats Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Hemostats Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Hemostats Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Hemostats Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Hemostats Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Hemostats Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Hemostats Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Hemostats Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Hemostats Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Hemostats Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Hemostats Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Hemostats Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Hemostats Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Hemostats Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Hemostats Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Hemostats Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Hemostats Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Hemostats Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Hemostats Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Hemostats Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Hemostats Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Hemostats Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Hemostats Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Hemostats Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Hemostats Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Hemostats Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Hemostats Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Hemostats Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Hemostats Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Hemostats Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Hemostats Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Hemostats Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Hemostats Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Hemostats Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Hemostats Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Hemostats Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Hemostats Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Hemostats Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Hemostats Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Hemostats Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Hemostats Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Hemostats Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Hemostats Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Hemostats Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Hemostats Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Hemostats Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Hemostats Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Hemostats Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Hemostats Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Hemostats Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Hemostats Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Hemostats Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Hemostats Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Hemostats Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Hemostats Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Hemostats Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Hemostats Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Hemostats Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Hemostats Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Hemostats Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Hemostats Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Hemostats Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Hemostats Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Hemostats Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Hemostats Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Hemostats Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Ethicon
  2. 8.1.1 Ethicon Company Information
  3. 8.1.2 Ethicon Business Overview
  4. 8.1.3 Ethicon Hemostats Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Ethicon Hemostats Product Portfolio
  6. 8.1.5 Ethicon Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Hemostats Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Hemostats Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Baxter International Inc.
  14. 8.3.1 Baxter International Inc. Company Information
  15. 8.3.2 Baxter International Inc. Business Overview
  16. 8.3.3 Baxter International Inc. Hemostats Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Baxter International Inc. Hemostats Product Portfolio
  18. 8.3.5 Baxter International Inc. Recent Developments
  19. 8.4 C. R. Bard
  20. 8.4.1 C. R. Bard Company Information
  21. 8.4.2 C. R. Bard Business Overview
  22. 8.4.3 C. R. Bard Hemostats Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 C. R. Bard Hemostats Product Portfolio
  24. 8.4.5 C. R. Bard Recent Developments
  25. 8.5 The Medicines Company
  26. 8.5.1 The Medicines Company Company Information
  27. 8.5.2 The Medicines Company Business Overview
  28. 8.5.3 The Medicines Company Hemostats Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 The Medicines Company Hemostats Product Portfolio
  30. 8.5.5 The Medicines Company Recent Developments
  31. 8.6 Anika Therapeutics
  32. 8.6.1 Anika Therapeutics Company Information
  33. 8.6.2 Anika Therapeutics Business Overview
  34. 8.6.3 Anika Therapeutics Hemostats Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Anika Therapeutics Hemostats Product Portfolio
  36. 8.6.5 Anika Therapeutics Recent Developments
  37. 8.7 Advanced Medical Solutions
  38. 8.7.1 Advanced Medical Solutions Company Information
  39. 8.7.2 Advanced Medical Solutions Business Overview
  40. 8.7.3 Advanced Medical Solutions Hemostats Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Advanced Medical Solutions Hemostats Product Portfolio
  42. 8.7.5 Advanced Medical Solutions Recent Developments
  43. 8.8 Integra LifeSciences Corporation
  44. 8.8.1 Integra LifeSciences Corporation Company Information
  45. 8.8.2 Integra LifeSciences Corporation Business Overview
  46. 8.8.3 Integra LifeSciences Corporation Hemostats Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Integra LifeSciences Corporation Hemostats Product Portfolio
  48. 8.8.5 Integra LifeSciences Corporation Recent Developments
  49. 8.9 B Braun Melsungen AG
  50. 8.9.1 B Braun Melsungen AG Company Information
  51. 8.9.2 B Braun Melsungen AG Business Overview
  52. 8.9.3 B Braun Melsungen AG Hemostats Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 B Braun Melsungen AG Hemostats Product Portfolio
  54. 8.9.5 B Braun Melsungen AG Recent Developments
  55. 8.10 Gelita Medical GmbH
  56. 8.10.1 Gelita Medical GmbH Company Information
  57. 8.10.2 Gelita Medical GmbH Business Overview
  58. 8.10.3 Gelita Medical GmbH Hemostats Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Gelita Medical GmbH Hemostats Product Portfolio
  60. 8.10.5 Gelita Medical GmbH Recent Developments
  61. 8.11 Equimedical
  62. 8.11.1 Equimedical Company Information
  63. 8.11.2 Equimedical Business Overview
  64. 8.11.3 Equimedical Hemostats Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Equimedical Hemostats Product Portfolio
  66. 8.11.5 Equimedical Recent Developments
  67. 8.12 Vascular Solutions
  68. 8.12.1 Vascular Solutions Company Information
  69. 8.12.2 Vascular Solutions Business Overview
  70. 8.12.3 Vascular Solutions Hemostats Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Vascular Solutions Hemostats Product Portfolio
  72. 8.12.5 Vascular Solutions Recent Developments
  73. 8.13 Marine Polymer Technologies
  74. 8.13.1 Marine Polymer Technologies Company Information
  75. 8.13.2 Marine Polymer Technologies Business Overview
  76. 8.13.3 Marine Polymer Technologies Hemostats Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Marine Polymer Technologies Hemostats Product Portfolio
  78. 8.13.5 Marine Polymer Technologies Recent Developments
  79. 8.14 Z-Medica, LLC
  80. 8.14.1 Z-Medica, LLC Company Information
  81. 8.14.2 Z-Medica, LLC Business Overview
  82. 8.14.3 Z-Medica, LLC Hemostats Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Z-Medica, LLC Hemostats Product Portfolio
  84. 8.14.5 Z-Medica, LLC Recent Developments
  85. 8.15 CryoLife
  86. 8.15.1 CryoLife Company Information
  87. 8.15.2 CryoLife Business Overview
  88. 8.15.3 CryoLife Hemostats Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 CryoLife Hemostats Product Portfolio
  90. 8.15.5 CryoLife Recent Developments
  91. 8.16 BioCer Entwicklungs-GmbH.
  92. 8.16.1 BioCer Entwicklungs-GmbH. Company Information
  93. 8.16.2 BioCer Entwicklungs-GmbH. Business Overview
  94. 8.16.3 BioCer Entwicklungs-GmbH. Hemostats Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 BioCer Entwicklungs-GmbH. Hemostats Product Portfolio
  96. 8.16.5 BioCer Entwicklungs-GmbH. Recent Developments
  97. 8.17 Biom'Up SAS
  98. 8.17.1 Biom'Up SAS Company Information
  99. 8.17.2 Biom'Up SAS Business Overview
  100. 8.17.3 Biom'Up SAS Hemostats Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Biom'Up SAS Hemostats Product Portfolio
  102. 8.17.5 Biom'Up SAS Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hemostats Value Chain Analysis
  2. 9.1.1 Hemostats Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hemostats Sales Mode & Process
  6. 9.2 Hemostats Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hemostats Distributors
  9. 9.2.3 Hemostats Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst